AN

Amol Natthuji Bhoge

Active Director Director DIN 10143136
DIN 10143136 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Natthuji Bhoge

Data last updated:

Amol Natthuji Bhoge is a Director at B-Pap Digital Pathology Private Limited (since 2023) and Director at Jyotika Surgical Private Limited (since 2023).

DIN 10143136
Primary Designation Director
First Appointment 01 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Dec 20232023Active
Jyotika Surgical Private Limited U32503UP2023PTC181272
Director01 May 20232023Active

Board colleagues of Amol Natthuji Bhoge

Directorship timeline

Open interactive timeline →
Jyotika Surgical Private Limited
B-Pap Digital Pathology Private Limited
Premium access

Shareholding and investment profile for Amol Natthuji Bhoge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Natthuji Bhoge

Amol Natthuji Bhoge currently holds 2 directorships: B-Pap Digital Pathology Private Limited (Director, since 11 Dec 2023); Jyotika Surgical Private Limited (Director, since 01 May 2023).

Amol Natthuji Bhoge was first appointed on 01 May 2023 as Director at Jyotika Surgical Private Limited.

The current boards of Amol Natthuji Bhoge's companies include Jyoti (B-Pap Digital Pathology Private Limited), Durbeen Kumar (Jyotika Surgical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available